Clinical Trial Update: Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating botulinum toxin injections into the urethral sphincter for dysfunctional voiding; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysfunctional Voiding

Drugs mentioned

• Botulinum toxin type A urethral sphincter injection (Botulinum toxin type A)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Dysfunctional Voiding | Phase 2 | Status: COMPLETED